Pharmacokinetics, Efficacy, Tolerability and Safety of a New Subcutaneous Human Immunoglobulin 16.5% in Primary Immune Deficiency

被引：0
|
作者：
Kobayashi, Roger [1 ]
Gupta, Sudhir [2 ,3 ]
Melamed, Isaac R. [4 ]
Mandujano, Jose F. [5 ]
Kobayashi, Ai Lan [6 ]
Ritchie, Bruce [7 ]
Turpel-Kantor, Eva [8 ]
Litzman, Jiri [9 ]
机构：
[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
[2] Univ Calif Irvine, Pathol & Lab Med, Med, Irvine, CA USA
[3] Univ Calif Irvine, Microbiol & Mol Genet, Irvine, CA USA
[4] IMMUNOe Res Ctr Centennial, Denver, CO USA
[5] Pediat Pulm Associates North TX, Frisco, PA USA
[6] Midlands Pediat, Papillion, NE 68046 USA
[7] Univ Alberta, Div Hematol, Dept Med, Fac Med & Dent, Edmonton, AB, Canada
[8] Octapharma Pharmazeutika Produktionsges MbH, Immunol, Vienna, Austria
[9] St Annes Univ Hosp, Dept Clin Immunol Allergol, Immunol, Brno, Czech Republic
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2018年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
128
引用
收藏
页码：391 / 392
页数：2
相关论文
共 50 条
  • [21] Efficacy, Pharmacokinetics, Safety, and Tolerability of FlebogammaA® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency
    Berger, Melvin
    Pinciaro, Paul J.
    Althaus, Arthur
    Ballow, Mark
    Chouksey, Akhilesh
    Moy, James
    Ochs, Hans
    Stein, Mark
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (02) : 321 - 329
  • [22] Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency
    Melvin Berger
    Paul J. Pinciaro
    Arthur Althaus
    Mark Ballow
    Akhilesh Chouksey
    James Moy
    Hans Ochs
    Mark Stein
    Journal of Clinical Immunology, 2010, 30 : 321 - 329
  • [23] Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
    Richard L. Wasserman
    Isaac Melamed
    Mark R. Stein
    Werner Engl
    Marlies Sharkhawy
    Heinz Leibl
    Jennifer Puck
    Arye Rubinstein
    Lisa Kobrynski
    Sudhir Gupta
    Andrew J. Grant
    Anoshie Ratnayake
    Wendell G. Richmond
    Joseph Church
    Leman Yel
    David Gelmont
    Journal of Clinical Immunology, 2016, 36 : 571 - 582
  • [24] Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
    Wasserman, Richard L.
    Melamed, Isaac
    Stein, Mark R.
    Engl, Werner
    Sharkhawy, Marlies
    Leibl, Heinz
    Puck, Jennifer
    Rubinstein, Arye
    Kobrynski, Lisa
    Gupta, Sudhir
    Grant, Andrew J.
    Ratnayake, Anoshie
    Richmond, Wendell G.
    Church, Joseph
    Yel, Leman
    Gelmont, David
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (06) : 571 - 582
  • [25] Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
    Perez, Elena E.
    Hebert, Jacques
    Ellis, Anne K.
    Alpan, Oral
    Lumry, William R.
    Shapiro, Ralph
    Suez, Daniel
    Mandujano, J. Fernando
    Wasserman, Richard L.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmuneA®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency
    Krivan, Gergely
    Chernyshova, Ludmila
    Kostyuchenko, Larysa
    Lange, Andrzej
    Nyul, Zoltan
    Derfalvi, Beata
    Musial, Jacek
    Bellon, Anne
    Kappler, Martin
    Sadoun, Alain
    Bernatowska, Ewa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (06) : 539 - 547
  • [27] A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency
    Gergely Krivan
    Ludmila Chernyshova
    Larysa Kostyuchenko
    Andrzej Lange
    Zoltan Nyul
    Beata Derfalvi
    Jacek Musial
    Anne Bellon
    Martin Kappler
    Alain Sadoun
    Ewa Bernatowska
    Journal of Clinical Immunology, 2017, 37 : 539 - 547
  • [28] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [29] Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability
    Wasserman, Richard L.
    Melamed, Isaac
    Kobrynski, Lisa
    Puck, Jennifer
    Gupta, Sudhir
    Doralt, Jennifer
    Sharkhawy, Marlies
    Engl, Werner
    Leibl, Heinz
    Gelmont, David
    Yel, Leman
    IMMUNOTHERAPY, 2016, 8 (10) : 1175 - 1185
  • [30] Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America
    Suez, Daniel
    Stein, Mark
    Gupta, Sudhir
    Hussain, Iftikhar
    Melamed, Isaac
    Paris, Kenneth
    Darter, Amy
    Bourgeois, Christelle
    Fritsch, Sandor
    Leibl, Heinz
    McCoy, Barbara
    Gelmont, David
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (07) : 700 - 712
12345